Connect Biopharma Holdings Limited Sponsored ADR (CNTB) vs Instil Bio, Inc. (TIL)

Connect Biopharma Holdings Limited Sponsored ADR and Instil Bio, Inc. are both Biotechnology companies. Connect Biopharma Holdings Limited Sponsored ADR and Instil Bio, Inc. are of similar size ($47.4M and $46.1M). Instil Bio, Inc. has the higher net margin (0.00% vs −2,298.9%) and the lower return on invested capital (−18.9% vs 0.00%). Across the 16 metrics below, Instil Bio, Inc. leads on 11 and Connect Biopharma Holdings Limited Sponsored ADR on 5.

Valuation

Metric CNTB TIL Biotechnology median
P/E n/m n/m 10.60
P/S 15.30 336.64 9.40
P/B 1.71 0.43 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 4.87 447.22 9.02
Earnings yield (163.01%) (65.26%) (32.88%)
Free cash flow yield (132.91%) (95.30%) (23.13%)

Profitability

Metric CNTB TIL Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (2,346.35%) 0.00% 0.00%
Net margin (2,298.93%) 0.00% 0.00%
Free cash flow margin (2,018.76%) 0.00% 0.00%
Return on equity (140.51%) (25.33%) (51.96%)
Return on assets (109.34%) (14.13%) (46.06%)
Return on invested capital 0.00% (18.94%) 0.00%

Growth

Metric CNTB TIL Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (257.14%) 6.06% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTB TIL Biotechnology median
Debt to equity 0.01 0.79 0.00
Current ratio 2.37 21.67 4.97
Net debt to EBITDA 0.77 (0.11) 1.01

Dividend

Metric CNTB TIL Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNTB TIL Biotechnology median
Market cap 46.08m 47.41m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack